BridgeMD
New treatment option for ERAS
Official title Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project
ClinicalTrials.gov ID: NCT06786819
What this study is testing
- What it's testing
- Cardiovascular diseases continue to be the leading cause of death worldwide. Among them, coronary artery disease has the greatest impact, being characterized as one of the main causes of death in Brazil over the last decade.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults over 18 years old
- Indication for primary isolated CABG (elective or urgent status)
- Own a personal cell phone
- Have internet access
- Knowledgeable in using the device
You likely can't join if
- Indication for associated surgery
- Glycosylated hemoglobin level greater than 8%
- Creatinine clearance less than 30 mL/min
- Pre-operative atrial fibrillation or use of pre-operative anticoagulation
- Hemoglobin less than 12 g/dL
- Users of illicit drugs
See the full eligibility criteria
- Adults over 18 years old
- Indication for primary isolated CABG (elective or urgent status)
- Own a personal cell phone
- Have internet access
- Knowledgeable in using the device
- Full understanding and agreement regarding the informed consent form (ICF)
- Indication for associated surgery
- Glycosylated hemoglobin level greater than 8%
- Creatinine clearance less than 30 mL/min
- Pre-operative atrial fibrillation or use of pre-operative anticoagulation
- Hemoglobin less than 12 g/dL
- Users of illicit drugs
- STS score greater than 4%
- Physical or mental disabilities that prevent adherence to the protocol
- Refusal by the patient or family member
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.